21,348
Total Claims
$7.0M
Drug Cost
2,621
Beneficiaries
$2,655
Cost/Patient
Peer Comparison vs. 17,757 Ophthalmology providers
+343%
Cost per patient vs peers
$2,655 vs $600 avg
+35%
Brand preference vs peers
49.4% vs 36.7% avg
Brand vs Generic
51% generic
Brand: 10,543 claims · $6.2M
Generic: 10,805 claims · $768K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Cyclosporine | 3,618 | $3.7M |
| Icosapent Ethyl | 998 | $575K |
| Cyclosporine | 877 | $491K |
| Cyclosporine | 337 | $296K |
| Latanoprostene Bunod | 454 | $191K |
| Bromfenac Sodium | 400 | $148K |
| Brimonidine Tartrate | 418 | $131K |
| Netarsudil Mesylate | 264 | $127K |
| Timolol Maleate/Pf | 169 | $126K |
| Brimonidine Tartrate/Timolol | 247 | $91K |
| Bimatoprost | 201 | $88K |
| Perfluorohexyloctane/Pf | 43 | $80K |
| Latanoprost | 3,508 | $79K |
| Lifitegrast | 77 | $77K |
| Icosapent Ethyl | 164 | $64K |
Prescribing Profile
44
Unique Drugs
Patient Profile
78
Avg Age
65%
Female
1.71
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data